FIELD: medicine; pharmacology.
SUBSTANCE: 17β-estradiole is offered as a means for modulation of H2-histamine heart receptors. The invention expands range of medicines affecting H2-histamine receptors and enables normalisation of H2-histamine heart receptor density during menopause.
EFFECT: improved efficiency of the drug.
3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT APPLIED FOR BRAIN DOPAMINE RECEPTORS MODLATION AT MENOPAUSE | 2007 |
|
RU2326671C1 |
| STEROID COMPOUNDS, METHOD FOR SELECTIVE MODIFICATION, PHARMACEUTICAL COMPOSITION | 2001 |
|
RU2255090C2 |
| GASTRIN ANTAGONISTS FOR TREATING AND PREVENTING OSTEOPOROSIS | 2014 |
|
RU2693484C1 |
| SCHEME OF ESTROGEN REPLENISHMENT | 2003 |
|
RU2340345C2 |
| METHOD FOR PREDICTION OF LEUKOCYTE TELOMERE LENGTH WITH UNDERLYING SEX STEROID REPLACEMENT THERAPY IN PATIENTS WITH TURNER SYNDROME OR PREMATURE OVARIAN FAILURE | 2024 |
|
RU2827907C1 |
| METHOD FOR DETECTING DNA-DAMAGING CAPACITY OF ESTROGENS | 2001 |
|
RU2223503C2 |
| METHOD OF TREATING BENIGN HYPERPLASTIC PROCESSES OF FEMALE REPRODUCTIVE SYSTEM | 2011 |
|
RU2471485C1 |
| METHOD FOR TREATING AFFECTED AMNESTIC FUNCTIONS | 2004 |
|
RU2268726C2 |
| PYRIDOPYRAZINEDIONE DERIVATIVE AND USE THEREOF AS ANTIULCER AGENT | 2010 |
|
RU2465274C2 |
| (-)-CIS-6(S)-PHENYL-5(R)-[4-(2-PYRROLIDINE-1-YLETHOXY)PHENYL]- -5,6,7,8-TETRAHYDRONAPHTHALINE-2-OL D-TARTRATE, METHOD OF ITS SYNTHESIS, METHOD OF PROPHYLAXIS OF STATES INFLUENCING WITH TO EFFECT OF ESTROGEN AGONISTS, PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2162465C2 |
